Orthofix Medical (NASDAQ:OFIX) Shares Gap Up on Insider Buying Activity

Shares of Orthofix Medical Inc. (NASDAQ:OFIX) gapped up prior to trading on Friday after an insider bought additional shares in the company. The stock had previously closed at $13.17, but opened at $13.79. Orthofix Medical shares last traded at $13.4610, with a volume of 77,899 shares trading hands.

Specifically, major shareholder Engine Capital Management, Lp acquired 13,061 shares of Orthofix Medical stock in a transaction dated Wednesday, February 25th. The stock was bought at an average cost of $12.96 per share, with a total value of $169,270.56. Following the completion of the transaction, the insider owned 3,673,092 shares of the company’s stock, valued at $47,603,272.32. The trade was a 0.36% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Engine Capital Management, Lp acquired 124,797 shares of the stock in a transaction dated Tuesday, February 24th. The stock was bought at an average price of $12.55 per share, for a total transaction of $1,566,202.35. Following the purchase, the insider owned 3,663,133 shares of the company’s stock, valued at $45,972,319.15. The trade was a 3.53% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on OFIX shares. TD Cowen began coverage on shares of Orthofix Medical in a report on Tuesday, January 27th. They issued a “hold” rating and a $14.00 price target for the company. Weiss Ratings restated a “sell (d-)” rating on shares of Orthofix Medical in a report on Thursday, January 22nd. Barrington Research decreased their target price on Orthofix Medical from $18.00 to $17.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, Canaccord Genuity Group cut their price target on Orthofix Medical from $24.00 to $20.00 and set a “buy” rating for the company in a report on Thursday. Three research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $18.25.

Orthofix Medical News Summary

Here are the key news stories impacting Orthofix Medical this week:

• Positive Sentiment: Engine Capital (a major shareholder) bought shares in two recent transactions — ~124,797 shares at ~$12.55 on Feb. 24 and an additional 13,061 shares at ~$12.96 on Feb. 25 — increasing its stake and signaling confidence from a large institutional holder. Engine Capital purchases OFIX shares
• Neutral Sentiment: Analysts trimmed price targets but kept several constructive ratings: Canaccord cut its target from $24 to $20 (still a “buy”) and others reduced targets modestly; consensus remains mixed (roughly a mid‑teens/$18-ish average target). This lowers upside expectations but does not indicate a broad teardown of the bull case. Analyst notes and price-target changes
• Negative Sentiment: Q4 results missed on EPS: reported ($0.06) vs. $0.44 expected; revenue was roughly in line but margins and ROE were negative — the EPS shortfall triggered investor selling and increased near-term skepticism. Shares down after earnings miss
• Negative Sentiment: Management flagged margin delays and issued revised 2026 guidance that shifts the narrative toward execution risk; until margin recovery and guidance clarity appear, the stock faces headwinds. Narrative shifting: margin delays and guidance

Orthofix Medical Stock Performance

The company has a current ratio of 2.45, a quick ratio of 1.38 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $535.79 million, a price-to-earnings ratio of -5.78 and a beta of 0.78. The stock has a fifty day moving average price of $14.08 and a 200-day moving average price of $14.71.

Orthofix Medical (NASDAQ:OFIX) last announced its quarterly earnings results on Tuesday, February 24th. The medical device company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.50). Orthofix Medical had a negative net margin of 11.21% and a negative return on equity of 20.38%. The company had revenue of $219.91 million during the quarter, compared to the consensus estimate of $218.72 million. As a group, analysts anticipate that Orthofix Medical Inc. will post -2.81 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Orthofix Medical

Several large investors have recently made changes to their positions in the company. Paradigm Capital Management Inc. NY lifted its holdings in Orthofix Medical by 34.6% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 3,340,600 shares of the medical device company’s stock valued at $37,248,000 after purchasing an additional 858,900 shares during the last quarter. Millennium Management LLC grew its stake in Orthofix Medical by 86.6% during the third quarter. Millennium Management LLC now owns 1,475,718 shares of the medical device company’s stock worth $21,605,000 after buying an additional 684,850 shares during the last quarter. Juniper Investment Company LLC increased its holdings in shares of Orthofix Medical by 23.3% during the fourth quarter. Juniper Investment Company LLC now owns 3,510,333 shares of the medical device company’s stock worth $53,217,000 after buying an additional 663,278 shares in the last quarter. Bank of America Corp DE raised its stake in shares of Orthofix Medical by 659.5% in the second quarter. Bank of America Corp DE now owns 687,410 shares of the medical device company’s stock valued at $7,665,000 after acquiring an additional 596,907 shares during the last quarter. Finally, Engine Capital Management LP boosted its holdings in shares of Orthofix Medical by 13.6% in the 2nd quarter. Engine Capital Management LP now owns 4,251,671 shares of the medical device company’s stock worth $47,406,000 after acquiring an additional 510,281 shares in the last quarter. Institutional investors own 89.76% of the company’s stock.

About Orthofix Medical

Orthofix Medical Inc (NASDAQ: OFIX) is a global medical device company focused on the design and development of innovative orthopedic and spinal solutions. The company’s core business is divided into two segments: spine and orthopedics. In the spine segment, Orthofix offers a range of titanium implants, biologics and portable bone growth stimulation devices designed to support spinal fusion, deformity correction and minimally invasive procedures. Its orthopedic segment encompasses products for fracture fixation, external fixation systems, trauma care and sports medicine, providing surgeons with implantable devices and instruments for complex bone reconstruction and healing.

Orthofix’s product portfolio includes strut systems, bone growth stimulators, interbody fusion devices and fixation hardware that address various indications such as degenerative disc disease, spinal deformities, non-unions and long-bone fractures.